0001870548-24-000001.txt : 20240617 0001870548-24-000001.hdr.sgml : 20240617 20240617143620 ACCESSION NUMBER: 0001870548-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 EFFECTIVENESS DATE: 20240617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alida Biosciences Inc. CENTRAL INDEX KEY: 0001870548 ORGANIZATION NAME: IRS NUMBER: 853573915 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-516210 FILM NUMBER: 241047806 BUSINESS ADDRESS: STREET 1: 14813 PRISCILLA STREET CITY: SAN DIEGO STATE: CA ZIP: 92129 BUSINESS PHONE: 720-375-1071 MAIL ADDRESS: STREET 1: 14813 PRISCILLA STREET CITY: SAN DIEGO STATE: CA ZIP: 92129 D 1 primary_doc.xml X0708 D LIVE 0001870548 Alida Biosciences Inc. 14813 PRISCILLA STREET SAN DIEGO CA CALIFORNIA 92129 720-375-1071 DELAWARE None None Corporation true 2020 Gudrun Stengel c/o Alida Biosciences, Inc. 14813 Priscilla Street San Diego CA CALIFORNIA 92129 Executive Officer Director John Drewry c/o Alida Biosciences, Inc. 14813 Priscilla Street San Diego CA CALIFORNIA 92129 Director Paul Conley c/o Alida Biosciences, Inc. 14813 Priscilla Street San Diego CA CALIFORNIA 92129 Director Landon Merrill c/o Alida Biosciences, Inc. 14813 Priscilla Street San Diego CA CALIFORNIA 92129 Director Biotechnology Decline to Disclose 06b false 2024-06-07 false true false 0 8520384 7520384 1000000 The total offering amount includes $1,020,384 on convertible securities. The total offering amount includes $3,750,000 committed to the issuer in future tranche closings. false 3 0 0 0 false Alida Biosciences Inc. /s/ Gudrun Stengel Gudrun Stengel President and CEO 2024-06-17